Literature DB >> 19622121

Microcirculatory modifications of psoriatic lesions during topical therapy.

Paolo Rosina1, Andrea Giovannini, Paolo Gisondi, Giampiero Girolomoni.   

Abstract

BACKGROUND/
PURPOSE: Videocapillaroscopy (VCP) can be used to explore microcirculatory modifications in skin diseases. Psoriasis presents a specifically altered capillaroscopic pattern with 'bushy' capillaries and a disarranged microangioarchitecture. The aim of the present study is to compare the clinical and capillaroscopic modifications of a psoriatic target lesion during topical therapy.
METHODS: Thirty patients with chronic plaque psoriasis were included in the study. Clinical and capillaroscopic modifications in comparable lesions of the elbows were analyzed during different topical therapies (calcipotriol, betamethasone dipropionate and calcipotriol plus betamethasone dipropionate) at baseline, and after 15 and 30 days of therapy. A clinical global score (modified Psoriasis Area Severity Index), the mecapillary density per square mm and the mean diameter of capillary loops were measured.
RESULTS: Topical therapy with combined betamethasone dipropionate and calcipotriol induced a higher decrease in erythema, infiltration and desquamation (P<0.001), and a significant reduction of the mean 'bush' diameter (P<0.001) and capillary number/mm(2) (P<0.05) compared with betamethasone and calcipotriol alone. Microvascular restoration to a normal pattern, as detected by VCP, was faster than clinical improvement (P<0.05).
CONCLUSION: Videocapillaroscopy is an easily executable and non-invasive technique that detects early microcirculatory changes in psoriasis during topical therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622121     DOI: 10.1111/j.1600-0846.2008.00336.x

Source DB:  PubMed          Journal:  Skin Res Technol        ISSN: 0909-752X            Impact factor:   2.365


  6 in total

Review 1.  Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

2.  Efficacy of calcipotriol plus betamethasone dipropionate foam on psoriatic skin lesions beyond human eyes: An observational study.

Authors:  Campanati Anna; Marani Andrea; Giannoni Melania; Orciani Monia; Fabiani Francesco; Napolitano Rachele; Arnesano Marco; Tomasini Enrico Primo; Offidani Annamaria
Journal:  Health Sci Rep       Date:  2022-04-26

3.  Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin.

Authors:  Giuseppe Stinco; Cinzia Buligan; Enzo Errichetti; Francesca Valent; Pasquale Patrone
Journal:  Dermatol Res Pract       Date:  2013-09-23

4.  Capillaroscopy in psoriatic and rheumatoid arthritis: a useful tool for differential diagnosis.

Authors:  Dario Graceffa; Beatrice Amorosi; Elisa Maiani; Claudio Bonifati; Maria Sole Chimenti; Roberto Perricone; Aldo Di Carlo
Journal:  Arthritis       Date:  2013-12-12

5.  Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.

Authors:  M Gooderham; J-M Debarre; J Keddy-Grant; Z Xu; M Kurvits; M Goodfield
Journal:  Br J Dermatol       Date:  2014-10-22       Impact factor: 9.302

6.  IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.

Authors:  Charlie Bridgewood; Gareth W Fearnley; Anna Berekmeri; Philip Laws; Tom Macleod; Sreenivasan Ponnambalam; Martin Stacey; Anne Graham; Miriam Wittmann
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.